Articles By Rob Wright, Chief Editor
What Went Right In 2020? My Top 5 List1/5/2021
Life Science Leader's Rob Wright reviews five things that went right in 2020.
New Year, New President, New Outlook1/4/2021
New Year’s is not just a time of celebration, but a point at which we step out of the day-to-day to reflect on how we did — and resolve to do better.
Frank Gupton – Revolutionizing Pharma Manufacturing From The Outside In1/4/2021
“I’ve gotten more press during the last six and a half months than in my 68 years on this earth,” jokes Frank Gupton, Ph.D., a professor at Virginia Commonwealth University who has been involved in some key recent developments in pharma manufacturing.
How A First-Time Pharma CEO Faces Hypergrowth1/4/2021
Jeffrey Nau, Ph.D., discusses the career path that led him to becoming president and CEO of Oyster Point Pharma, a publicly traded biopharma now valued at more than $550 million and on the brink of commercial launch.
What Do 10 Biopharma Finance Experts Expect for 2021?12/1/2020
We invited 10 biopharmaceutical industry finance experts to provide their perspectives on everything from remote work, to supply chains, to the reshoring of U.S. biopharmaceutical manufacturing operations.
The Future Of Biopharma Manufacturing Has Never Been More Critical12/1/2020
Here’s what six biopharmaceutical manufacturing executives have to say on emerging manufacturing innovations, key trends to pay attention to in 2021 (and beyond), and so much more.
Reflection And Projection — 15 CEOs Map Biopharma’s Present And Future12/1/2020
2020 was the year that everything changed, including this year’s annual CEO outlook article. Normally fully focused on the future, this year’s version contains some reflection, which seems appropriate in our new norm.
What’s The Annual Outlook For Life Sciences In 2021?12/1/2020
As we’ve done previously, this year we posed many questions to lots of executives across a variety of life science industry disciplines, and here you will gain perspectives on what to expect on biosimilars to outsourcing, and everything in between.
Amidst COVID-19 There Is Much To Be Thankful11/2/2020
These unprecedented times may have provided unprecedented adversity, but there is still so much for which to be thankful. Let’s review.